Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3835_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
13 Мб
Скачать
☆
3 The Integration of IVUS and OCT 63
https://t.me/medicina_free
the aperture of the GRIN lens is larger than GRIN fiber probe, the theoretical lateral resolution of a GRIN lens probe is usually better; secondly, a GRIN lens usually performs with a higher-quality gradient refractive index profile than that of a GRIN fiber and less spherical aberration t han a ball lens, which makes its lateral resolution even better.
After separately fabricating the OCT sub-probe and the ultrasound transducer, these two components can be fixed inside a stainless steel (Yin et al. 2010) or poly- imide (Yin et al. 2011) tube. On the tube, a window needs to be cut to allow the light beam and the sound wave to exit. The different arrangements of the transducer and the OCT sub-probe have been proposed, to minimize the size of the integrated probe while preserving its imaging performance. As they are all designed for intracoronary applications, we review them later in this chapter.
Outer Sheath Design
An outer sheath can help avoid cross-contamination between the imaging probe and the biological tissue. Furthermore, the sheath is designed to remain stationary when the probe rotates for scanning. Such a design can prevent the rotating probe from contacting and damaging the tissue.
The design of an IVUS-OCT sheath is similar to that of a clinically used IVOCT catheter, except that special attention needs to be paid to the selection of its material. The sheath material has to allow both light beams and sound waves to pass through without high attenuation or reflection (Li and Chen 2016).
Since the sheath is a cylindrical tube, its curved surface makes the light beam diverge faster in one axis than in the other axis. Consequently, astigmatism is gener­ated to the light beam leaving the sheath. Various methods of astigmatism correction can be used, such as purging (Katwal and Lopez 2015) and using the ellipse ball-lens design(Tanetal.2012). Purging means injecting a high refractive index medium (such as a saline solution or a contrast agent) into the lumen between the imaging probe and the sheath. Since the media in both s ides of the curved interface have sim­ilar high refractive indices, the amount of undesired focusing is reduced. In a later design (Tan et al. 2012), a ball lens with different radii in two axes was employed so as to focus light to different extents and compensate astigmatism caused by the curved surface of the sheath.
Key Measures
To characterize the imaging performance of the system we built, two key measures, resolution and SNR, are commonly used. Here, we present equations that relate the imaging performance, the system speed and the probe size, and briefly dis­cuss their implications. Technical approaches to maintain high performance without significantly increasing the system complexity or reducing the imaging speed are summarized later in this section.
64 J. Li et al.
https://t.me/medicina_free
Resolution
Resolution is defined as the minimal resolvable distance between two-point objects. Transverse resolution For both ultrasound and OCT technologies, the transverse resolution is determined by the beam spot exiting the imaging sensor.
In ultrasound, the theoretical lateral resolution is typically expressed as (Biomed­ical 2006;Ng2011):
V
=
R
L
· F#(1)
f
0
where V is the speed of ultrasound, f focal length l
and the outer diameter D of the transducer aperture.
f,
is central frequency, F# is the quotient of the
0
In OCT, the theoretical lateral resolution is related to the numerical aperture (NA) of the imaging optics:
λ
NA
0
(2)
where λ
= 0.37
R
L
is the center wavelength of the OCT light source.
0
In reality, focusing aberration usually occurs. It deteriorates the beam quality and, thus, makes the actual transverse resolutions worse than the theoretical ones calculated by Eqs. (1) and (2). Axial resolution Unlike transverse resolution, axial resolution is independent of the focusing ability of an imaging sensor.
In ultrasound, the axial resolution can be estimated by the following equation (Biomedical 2006;Ng2011):
R
A
=
2 · fo· BW
V
(3)
where BW is the fractional frequency bandwidth.
For an OCT sub-system with a Gaussian spectrum light source, the axial resolution is determined by the center frequency and the bandwidth of the light source λ:
2
λ
2In2
R
=
A
nsπ
λ
0
(4)
where n
is the refractive index of the sample.
s
For an OCT sub-system with a non-Gaussian spectrum light source and/or with chromatic dispersion between the sample and reference arms, estimation of its axial resolution by the above equation can be inaccurate. A measurement of the full­width-at-half-maximum (FWHM) of the axial point spread function is usually used to obtain the actual axial resolution. SNR Classically, the SNR of an imaging system is the ratio of the peak signal to the root-mean-square of the noise level.
3 The Integration of IVUS and OCT 65
https://t.me/medicina_free
In an ultrasound sub-system, the SNR is related to the pulse duration, which is inversely proportional to the imaging speed, and the lateral beam width (Werkmeister et al. 2013):
A(f
SNR =
16
ρvwxwyt
n(f
)
0
)
0
(5)
where w speed in the medium, t is the pulse duration, A(f at the center frequency, and n(f
and wyare the beam width in the x-and y-axis, respectively, v is sound
x
is the amplitude of the signal
)
0
is the noise at the center frequency.
)
0
In shot-noise limit FDOCT (i.e., the system used in the integrated IVUS-OCT system) the SNR can be expressed by the following equation (Bouma et al. 2008):
ηP
hυ f
s
A
(6)
where f
SNR =
is the A-line speed, Psis the signal power of the sample arm, hυ is the
A
single-photon energy, and η is the detector sensitivity. As illustrated by this equation, the power of the sample arm is usually positively related to the SNR. Accordingly, an OCT sub-system usually uses a 90:10 or 80:20 coupler that transmits more lights to the sample arm than to the reference arm, so as to improve the SNR.
Similarly, as can be seen from Eqs. (5) and (6), SNRs of both ultrasound and OCT sub-systems will drop as the imaging speed goes up. Thus, many challenges must be overcome so as to achieve an ultrafast high-SNR IVUS-OCT system, which is introduced in the section ‘Technical Advances: high-speed imaging system’. In addition, the aperture size of an imaging sensor influences its lateral resolution and the SNR according to Eqs. (1), (2), and (5). A summary on approaches to overcome the trade-off between the performance and the size of an integrated probe is provided in the section ‘Technical Advances: miniaturized IVUS-OCT probe’.
Case Study: IVUS-OCT to Detect Vulnerable Plaques
Background
It was briefly mentioned in the introduction that the development of integrated IVUS­OCT technology was driven by the need for identifying vulnerable plaques. A thin­cap fibroatheroma (TCFA), the most common type of vulnerable plaques, is prone to rupture and trigger thrombus formation. Thrombus can block blood flow within coronary arteries and subsequently results in acute coronary syndrome (ACS). How­ever, the majority of plaques in arteries are stable and do not cause ACS (Farooq et al.
2009; Sanz and Fayad 2008; Nakano et al. 2012; Ferrante et al. 2010). Treating a
plaque without assessing its vulnerability may lead to overtreatment of stable plaques,
66 J. Li et al.
https://t.me/medicina_free
which is not recommended by clinical guidelines, and could result in an increase of complications (Waxman et al. 2006;Falketal.2013; Montalescot et al. 2013). On the contrary, identifying vulnerable plaques and optimizing therapies accordingly (Fassa et al. 2005; Kereiakes et al. 2003; Wykrzykowska et al. 2012) are expected to improve clinical outcomes. A tool that has both a high positive predictive value and a high negative predictive value in detecting vulnerable plaques, i.e., tell cardiolo­gists to locally treat a plaque or not (Mintz 2016), is needed clinically. It holds great promise in preventing plaque rupture and life-threatening sequelae (Fleg et al. 2012; Waxman et al. 2006). Many imaging techniques have been used to image plaques (Lusis 2000; Narula and Strauss 2007), including conventional fluoroscopic angiog­raphy, magnetic resonance imaging (MRI), X-ray or computed tomography (CT), OCT, IVUS with virtual histology (VH), angioscopy and near-infrared fluorescence (NIRF) imaging (Puri et al. 2011; Sanz and Fayad 2008; Narula and Strauss 2007). However, none of these currently available technologies is sufficient to accurately evaluate the vulnerability of a plaque (Sanz and Fayad 2008;Purietal.2011).
Particularly, a stand-alone intravascular imaging modality can visualize a certain feature of a TCFA,but not all key features. IVUS, with its deep penetration, can image the large necrotic pool and the total plaque volume of a TCFA. The limitation of IVUS is its resolution (~100 µm). On the contrary, OCT, with its high resolution, permits a definite measurement of the cap thickness of a plaque. This critical parameter for characterizing TCFA is otherwise not accessible by other in vivo imaging techniques (Farooq et al. 2009). However, the primary limitation of OCT for this application is its penetration depth (~1.5 mm in tissue) which is not enough to reveal the necrotic core size. Clinical evidence has also proven these limitations. A large cohort IVUS trial confirmed that IVUS alone is not sufficient in identifying vulnerable plaques (Stone et al. 2011, 2012). Similarly, clinical data (Mintz 2016) also revealed that the diagnostic accuracy of OCT to identify vulnerable plaque is limited mainly due to its shallow penetration depth and low molecular specificity (Virmani 2011; Prati et al.
2010; Bezerra et al. 2009).
As illustrated above, the characteristics of TCFA highlight the necessity of an imaging technique with a high resolution to identify the thin cap and with a deep enough penetration depth to visualize the necrotic core s imultaneously. Moreover, several clinical studies were reported and validated the usefulness of a combined use of IVUS and OCT in characterizing plaque compositions (Kawasaki et al. 2006; Rieber et al. 2006) and detecting vulnerable plaques (Sawada et al. 2008; Zhang et al.
2014; Fujii et al. 2015; Mintz 2016). All these findings motivate the development of
a fully integrated intracoronary ultrasound-OCT system.
Technical Advances
In this section, we reviewthe technical development of the IVUS-OCT technology for imaging vulnerable plaques in coronary arteries. Apart from common considerations of an integrated IVUS-OCT system previously described, there are several particular
3 The Integration of IVUS and OCT 67
https://t.me/medicina_free
technical challenges that need to be addressed to translate this technology for clinical intravascular imaging. These challenges include miniaturizing the IVUS-OCT probe, increasing the imaging speed and optimizing the flushing process.
Miniaturized IVUS-OCT Probe
The inner diameter of a human coronary artery is 2–5 mm. Patients with atherosclero­sis may have coronary arteries that are even narrower. Accordingly, an intracoronary imaging catheter (including the imaging probe and the outer sheath) is usually made with an OD smaller than 1 mm and with a soft tip to avoid scraping and damaging the coronary artery wall during imaging procedures. However, over-reducing the size (either the thickness or the aperture area) of an OCT or ultrasound probe will sacri­fice the performance of the integrated imaging system. The aperture size of a sensor (either a transducer or an OCT lens) limits the lateral resolution and SNR that a system can achieve, based on Eqs. (1), (2), and (5). In addition, as described previously, the thicknesses of the piezoelectric element of a transducer affect its central frequency, while thicknesses of the matching and backing layers influence the sensitivity and the impedance of a transducer. Thus, the challenge of making an IVUS-OCT catheter is to maintain good imaging quality of IVUS and OCT without making the crossing profile of the IVUS-OCT catheter larger than 1 mm. To address this technical chal­lenge, an innovative probe arrangement that can make good use of the space has to be applied.
In 2010, our groups published the first demonstration of an integrated IVUS­OCT probe (Yin et al. 2010). This probe applied a side-by-side arrangement and achieved an OD of 2.4 mm, see Fig. 3.3a. The size of the GRIN lens used in the OCT probe had an OD of 0.5 mm, and the size of the PZT transducer was around
2
0.4 × 0.4 mm
. To better use space and provide coaxial IVUS-OCT imaging abil­ity, an inside-outside arrangement was proposed and achieved (Li et al. 2010)by placing a focused ring transducer (made by LiNbO
) around a 0.7 mm-OD GRIN
3
lens, see Fig. 3.3b. Although the OD of this prototype was the same as the former design (2.4 mm), apertures for the OCT and IVUS sensors were both larger, enabling higher lateral resolutions. Particularly with a large-aperture focused transducer, the measured lateral resolution of the IVUS sub-system was as high as 22 µm.
In 2011, we reported the first IVUS-OCT probe suitable for in vivo imaging in a coronary-sized artery (Yin et al. 2011). A sequential arrangement was applied to reduce the probe profile. The OD of the integrated probe was 0.68 mm. It utilized a relatively large GRIN lens (0.35 mm OD) to maintain high lateral resolution of the OCT sub-system. PMN-PT material, which has high k
, εs/ε0,and d33,was
t
used to fabricate a miniaturized transducer while maintaining high sensitivity of the ultrasound sub-system. However, there is a 2-mm longitudinal offset between the transducer and the OCT sensor due to the sequential arrangement, see Fig. 3.3c. Although the obtained ultrasound and OCT signal could be co-registered by post­processing, a real-time automatically co-registered arrangement would still be ideal for providing real-time guidance for interventions in the cardiac catheter laboratory
68 J. Li et al.
https://t.me/medicina_free
Fig. 3.3 Schematics of different IVUS-OCT probe designs. a Side-by-side arrangement (Yin et al.
2010); b inside–outside arrangement (Li et al. 2010); c sequential arrangement (Yin et al. 2011);
d back-to-back arrangement (Li et al. 2013b); e side-by-side 90° apart design (Li et al. 2013a)
in a hospital. Moreover, the offset made this probe have a long rigid part [5-mm long, similar to previously reported designs (Li et al. 2010; Yin et al. 2010)]. It would be difficult to navigate this probe through a coronary artery that has a narrow lumen and sharp bends. To overcome these drawbacks, a modified version was reported in 2013 (Li et al. 2013b). This probe applied a “back-to-back” arrangement, see Fig. 3.3d, to ensure a coaxial positioning of the transducer and the OCT sensor, while keep a small OD. In addition, a ball lens (OD: 0.28 mm) instead of a miniaturized GRIN lens (OD: 0.35 mm) was used to further reduce the size of the OCT probe. The OD of this probe was 0.9 mm, and the rigid part of this probe was only 2.5 mm long, which was the shortest ever reported. Apart from these designs proposed by our group, the ultrasound group led by F. Stuart Foster and the OCT group led by Victor X. D. Yang, in Canada have also reported an IVUS-OCT probe design, see Fig. 3.3e. The probe used a side-by-side 90° apart design and a ultrasmall GRIN lens (OD 0.14 mm) to reduce the size of the IVUS-OCT probe (Li et al. 2013a). The OD of this probe was 1 mm. F. Foster and V. Yang also briefly reported a new probe design in a review
3 The Integration of IVUS and OCT 69
https://t.me/medicina_free
paper (Bourantas et al. 2016). Although limited information was provided, it was stated that this new IVUS-OCT probe allowed optics to reside within the ultrasound transducer to facilitate miniaturization and the IVUS and OCT beams travel in the same direction. These four designs (Yin et al. 2011;Lietal.2013a, b; Bourantas et al. 2016) described above ensure that the OD of the probe is smaller than 1 mm and are likely to provide safe access to coronary arteries.
High-Speed Imaging System
During intracoronary imaging, the imaging catheter stays inside a coronary artery and may partially block the normal blood flow. Coronary arteries supply blood to cardiac muscle that pumps oxygen-rich blood throughout the body. Due to this critical role of the coronary artery, the time needed for imaging the artery, i.e., the time to keep a catheter inside it, should be as short as possible. Furthermore, a short imaging time will also reduce the risk of flushing-induced complications. Because blood causes high optical attenuation, flushing an artery is often necessary to generate clear IVOCT images (Li et al. 2015a). However, the longer it takes to image, the more flushing agents will be injected, which can be harmful for the patient (Ozaki et al. 2012). To ensure the safety of using an IVUS-OCT catheter in patients, a vast amount of effort was put in reducing the time needed to image a coronary artery and, accordingly, increasing the imaging speed.
By innovatively applying state-of-the-art devices that were originally developed for other fields (including optical communication and computer engineering) in the development of an IVUS-OCT system, the imaging speed of IVUS-OCT has been greatly increased. The first reported IVUS-OCT system (Yin et al. 2010) was able to image at 1 fps by using separated DAQ cards for US and OCT sub-systems. Utilizing a more powerful dual-channel DAQ card and a GPU for parallel computing, 4 fps was accomplished (Yin et al. 2011). Subsequently, a 20-fps system was achieved (Li et al. 2014a, c) by using a modified probe design that ensures a more uniform rotation and smoother transmission of the rotation from the proximal to the distal end. With a recently developed ultrasound pulser and a more advanced design of a customized slip ring, the achievement of 72 fps was reported (Li et al. 2015b). By using such a system, IVUS-OCT imaging of a coronary artery can be conducted within 4 s. As a clinically used IVOCT system takes 3–6 s to image a coronary artery, it is reasonable to believe that the imaging speed of this IVUS-OCT system is sufficient for clinical applications.
Flushing
Intracoronary imaging is conducted in an environment naturally filled with blood. As blood is a strong attenuation source for OCT and high-frequency ultrasound signals, finding an optimal flushing agent that works well for both IVUS and OCT can improve in vivo imaging quality.
70 J. Li et al.
https://t.me/medicina_free
Flushing media with high viscosity can result in efficient blood displacement and clear OCT images (Suter et al. 2015). However,flushing media with too high viscosity will reduce the SNR of an ultrasound sub-system (Li et al. 2015a). This is because friction and thermal consumption of energy are induced when sound propagates through such media (Stokes 1849). To evaluate the effectiveness of different flushing agents and speeds and optimize flushing for both ultrasound and OCT sub-systems, we performed a well-controlled quantitative test in an in vitro model that mimics the human arterial system and in vivo in a rabbit (Li et al. 2015a).
Apart from considering the effectiveness of a flushing medium, toxicity is also a crucial concern. As the flushing agent is injected into blood and can be circulated through the whole body of the patient, we need to avoid using a medium with high toxicity (McCullough 2008; Ozaki et al. 2012). In consideration of both flushing effectiveness and toxicity, it was found that Dextran is the best among three flushing media we used (mannitol, Iohexol, and dextran). Other OCT flushing media, such as glucose solution and propylene glycol (Tuchin et al. 2002) and iodixanol (Suter et al.
2015), may work too but need to be validated with an IVUS-OCT system in vivo.
These above developments have made the intracoronary application of IVUS­OCT technically possible. Meanwhile, experiments in animal and human specimens have been conducted to evaluate the clinical adaptability and the safety of these developments which are reviewed below.
In Vivo and Ex Vivo Validations
In Vivo Validations
Rabbit and porcine models are commonly used (Ohtsuki et al. 2001) prior to human experiments to validate the design of an intravascular imaging system. The aortas of rabbits and the coronary arteries of pigs are comparable to the caliber of human coronary arteries. In addition, rabbits and pigs can grow lesions similar to human atherosclerotic plaques (Kolodgie et al. 2003; Schoenhagen et al. 2001).
The first in vivo demonstration of an integrated IVUS-OCT probe was achieved in a rabbit (Yin et al. 2011). IVUS-OCT image pairs of a rabbit aorta were acquired with a 4-fps system and a 0.68 mm-OD probe. The first in vivo intracoronary IVUS­OCT imaging was conducted in a pig (Li et al. 2014a). Imaging was performed in a swine left anterior descending artery by using a 20-fps system and a 3.7 F IVUS­OCT catheter (Fig. 3.4). Successively, an in vivo rabbit experiment validated the effectiveness of using dextran as the flushing agent for simultaneous IVUS-OCT imaging (Li et al. 2015a). In 2015, the safe use of an ultrafast IVUS-OCT system (72 fps) was demonstrated in live rabbits (Li et al. 2015b).
3 The Integration of IVUS and OCT 71
https://t.me/medicina_free
Fig. 3.4 An OCT-IVUS image pair obtained in a normal swine coronary artery in vivo. a OCT image, b IVUS image, c corresponding H&E histology. G: guide wire. T: tissue. V: vessel. I: intima. E: EEL. A: adventitia. Scale bar: 1 mm. Reprint from (Li et al. 2014a) with permission
Ex Vivo Validation
Although animal experiments can evaluate the clinical adaptability and the safety of these developed systems, few TCFA-like plaques can be found in animal models (Brezinski 2006; Rekhter 2002; Kolodgie et al. 2003; Rekhter et al. 1998). Thus, human cadaver samples were used to evaluate whether a device can acurately detect TCFA. In 2015, we reported our work on demonstrating the usefulness of IVUS­OCT in distinguishing a TCFA from false TCFAs (Li et al. 2015b), i.e., plaques that are easily misdiagnosed by stand-alone IVUS or OCT. Fibrous caps were shown as signal high regions in the OCT images (Fig. 3.5Ia, IIa, and IIIa). In IVUS and OCT images, the signal-low regions behind the caps revealed the presence of necrotic or lipid pools. As anticipated, the OCT imaging capability of the IVUS-OCT catheter differentiated thin cap (Fig. 3.5Ia) and thick cap (Fig. 3.5IIa) whereas the ultra- sound imaging capability in the IVUS-OCT catheter differentiated large (Fig. 3.5Ib) and small (Fig. 3.5IIIb) necrotic cores. IVUS-OCT with simultaneous dual-imaging capabilities clearly discerned differences between TCFA and false TCFA (plaques with a thick cap or a small necrotic core).
Other Studies Related to IVUS-OCT
IVUS-OCT for Angioplasty Planning and Follow-Up
Apart from being used for the detection of TCFA, IVUS-OCT may also play an important role in angioplasty planning and follow-up.
Angioplasty is a commonly used non-surgical procedure to treat arteries, such as coronary or peripheral arteries (Arthurs et al. 2010), that were narrowed by atherosclerotic plaques. During this procedure, stents that open up arteries are usually
72 J. Li et al.
https://t.me/medicina_free
Fig. 3.5 Characterizing human atherosclerotic plaques by the ultrafast IVUS-OCT system. First row: Example of a TCFA. (Ia) OCT image in which arrows point at the fibrous cap; (Ib)corre­sponding IVUS image indicates the location of necrotic core; (Ic) photograph of the corresponding histology slide with CD 68 stain, highlighting macrophages and necrotic core. Middle row: A false­positive case of TCFA diagnosis based on IVUS only (IIb) was produced due to the insufficient resolution and sensitivity. Size of the thick cap can be determined by the corresponding OCT (IIa) and CD 68 histology (IIc). Bottom row: A false-positive case of TCFA diagnosis based on OCT only (IIIa) was produced due to OCT’s limited penetration depth. A small lipid pool can be determined by IVUS (IIIb) and CD 68 histology (IIIc). Arrows denote the fibrous cap. NC: necrotic core; SLP: small lipid pool. Scale bar: 0.5 mm. Reprint from the reference Li et al. (2015b) with permission